We are live on ! Find out more
AUPH icon

Aurinia Pharmaceuticals
AUPH

132 hedge funds and large institutions have $956M invested in Aurinia Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 47 increasing their positions, 31 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 31

36% more call options, than puts

Call options by funds: $33.8M | Put options by funds: $24.9M

32% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 22

9% more capital invested

Capital invested by funds: $880M → $956M (+$76M)

6% more funds holding

Funds holding: 125 → 132 (+7)

1.76% less ownership

Funds ownership: 54.03% → 52.28% (-1.8%)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
132
Holders Change
+7
Holders Change %
+5.6%
% of All Funds
2.71%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.08%
New
29
Increased
47
Reduced
31
Closed
22
Calls
$33.8M
Puts
$24.9M
Net Calls
+$8.91M
Net Calls Change
+$2.53M

Top Buyers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
+$20.7M
2
KCM
Kingdon Capital Management
New York
+$14.2M
3
EP
Eversept Partners
New York
+$8.78M
4
PAMU
Pictet Asset Management (UK)
United Kingdom
+$8.65M
5
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
+$6.03M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$36.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$32.1M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$13.2M
4
ACP
Acuta Capital Partners
California
-$11.2M
5
Citadel Advisors
Citadel Advisors
Florida
-$5.74M
Name Holding Trade Value Shares
Change 		Change in
Stake
DMK
51
David M. Knott
$1.87M +$1.72M +107,510 +1,473%
IFG
52
Independent Financial Group
California
$1.84M – – –
Jane Street
53
Jane Street
New York
$1.74M +$1.72M +107,176 New
UBS Group
54
UBS Group
Switzerland
$1.65M -$330K -20,620 -17%
Geode Capital Management
55
Geode Capital Management
Massachusetts
$1.59M +$31.1K +1,943 +2%
Morgan Stanley
56
Morgan Stanley
New York
$1.54M +$620K +38,712 +69%
Rockefeller Capital Management
57
Rockefeller Capital Management
New York
$1.53M +$16K +1,000 +1%
Verition Fund Management
58
Verition Fund Management
Connecticut
$1.52M +$537K +33,555 +56%
PM
59
Prosight Management
Texas
$1.5M +$1.47M +92,000 New
TCM
60
Tekla Capital Management
Massachusetts
$1.48M – – –
Two Sigma Advisers
61
Two Sigma Advisers
New York
$1.42M +$215K +13,400 +18%
NFG
62
Norris Financial Group
South Carolina
$1.37M +$309K +19,301 +30%
UBS AM
63
UBS AM
Illinois
$1.28M +$94.5K +5,900 +8%
Barclays
64
Barclays
United Kingdom
$1.26M – – –
Creative Planning
65
Creative Planning
Kansas
$1.11M -$4.8K -300 -0.4%
CS
66
Credit Suisse
Switzerland
$1.07M -$65.1K -4,065 -6%
CIBC Asset Management
67
CIBC Asset Management
Ontario, Canada
$1.04M +$1.03M +64,080 New
LP
68
LMR Partners
United Kingdom
$1.03M – – –
GIA
69
Gladstone Institutional Advisory
Florida
$1.01M +$112K +6,998 +13%
EAM
70
Erste Asset Management
Austria
$1M – – –
Vanguard Group
71
Vanguard Group
Pennsylvania
$931K -$638K -39,844 -41%
CL
72
CSS LLC
Illinois
$820K +$518K +32,333 +178%
FAM
73
Fred Alger Management
New York
$813K -$96.1K -6,000 -11%
B
74
Bailard
California
$813K +$801K +50,000 New
MS
75
Maven Securities
Jersey
$813K +$801K +50,000 New
1 2
3
4 5

AUPH Hedge Fund Activity: Q2 2020 in Review

132 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Aurinia Pharmaceuticals (AUPH) for Q2 2020, worth a combined $956M — up 8.6% from $880M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new AUPH positions and 22 closed out — a net gain of 7 holders — while 47 added to existing stakes and 31 trimmed.

The largest buyer was Avidity Partners Management, adding an estimated $20.7M. The largest seller was Consonance Capital Management, cutting an estimated $36.6M.

  • 132 institutional investors held Aurinia Pharmaceuticals (AUPH) as of Q2 2020, up from 125 in Q1 2020.
  • Funds reported $956M of Aurinia Pharmaceuticals stock for Q2 2020, up 8.6% quarter-over-quarter.
  • 29 funds opened new Aurinia Pharmaceuticals positions in Q2 2020 and 22 closed out, a net change of +7 holders.
  • The largest Aurinia Pharmaceuticals buyer in Q2 2020 was Avidity Partners Management, an estimated $20.7M added.
  • The largest Aurinia Pharmaceuticals seller in Q2 2020 was Consonance Capital Management, an estimated $36.6M sold.

Based on aggregated 13F filings for Q2 2020.